09.03.2013 Views

Inhibitor SourceBook™ Second Edition

Inhibitor SourceBook™ Second Edition

Inhibitor SourceBook™ Second Edition

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Phosphorylation/Dephosphorylation<br />

Product Cat. No. Comments Size Price<br />

JAK <strong>Inhibitor</strong> I 420099 {2-(1,1-Dimethylethyl)-9-fluoro-3,6-dihydro-7H-benz[h]-imidaz[4,5-f]isoquinolin-7-one}<br />

A potent inhibitor of Janus protein tyrosine Kinases (JAKs). Displays potent inhibitory<br />

activity against JAK (IC 50 = 5 nM for murine JAK ), JAK2 (IC 50 = nM), JAK3 (K i =<br />

5 nM), and Tyk2 (IC 50 = nM).<br />

N InSolution JAK<br />

<strong>Inhibitor</strong> I<br />

420097 {2-(1,1-Dimethylethyl)-9-fluoro-3,6-dihydro-7H-benz[h]-imidaz[4,5-f]isoquinolin-7-one}<br />

A 0 mM (500 mg/ 62 ml) solution of JAK <strong>Inhibitor</strong> I (Cat. No. 420099) in DMSO.<br />

N JAK2 <strong>Inhibitor</strong> II 420132 (1,2,3,4,5,6-Hexabromocyclohexane)<br />

A cell-permeable hexabromocyclohexane compound that acts as a specific and direct<br />

inhibitor of JAK2 autophosphorylation (maximal inhibition at 50 mM in BSC-40 cells<br />

overexpressing JAK2).<br />

JAK3 <strong>Inhibitor</strong> I 420101 [4-(4´-Hydroxyphenyl)amino-6,7-dimethoxyquinazoline; WHI-P131]<br />

A specific inhibitor of JAK3 (IC 50 = 78 mM). Does not affect the activity of JAK , JAK2,<br />

ZAP/Syk, or Src tyrosine kinases.<br />

JAK3 <strong>Inhibitor</strong> II 420104 {4-[(3´-Bromo-4´-hydroxyphenyl)amino]-6,7-dimethoxyquinazoline; WHI-P154}<br />

A potent, cell-permeable inhibitor of JAK3 that is reported to kill glioblastoma cells<br />

(IC 50 = 8 3 nM).<br />

JAK3 <strong>Inhibitor</strong> III 420106 [4-(3´,5´-Dibromo-4-hydroxyphenyl)amino-6,7-dimethoxyquinazoline; WHI-P97]<br />

A potent and specific inhibitor of JAK3 (IC 50 = mM).<br />

JAK3 <strong>Inhibitor</strong> IV 420121 [2-Naphthyl-(N-isopropyl,N-benzyl)-b-aminoethylketone, HCI; ZM 39923]<br />

A potent and selective ATP-competitive inhibitor of JAK3 (pIC 50 = 7. ). Weakly inhibits<br />

other tyrosine kinases (pIC 50 = 5.6 for EGF-R; 4.4 for JAK ). In neutral buffer undergoes<br />

a retro-Michael breakdown (t /2 = 36 min at 25˚C, pH 7.43) to the active analog 2-naphthylvinyl<br />

ketone (Cat. No. 420 22) [pIC 50 = 6.8 for JAK3; 5.0 for EGF-R; 4.7 for JAK ].<br />

JAK3 <strong>Inhibitor</strong> V 420122 [(2-Naphthylvinyl Ketone); ZM 449829]<br />

A breakdown product of JAK3 <strong>Inhibitor</strong>-IV (Cat. No. 420 2 ) with similar inhibitory<br />

activities (pIC 50 = 6.8 for JAK3; 5.0 for EGF-R; 4.7 for JAK ). Also inhibits STAT-5<br />

phosphorylation and T-cell proliferation.<br />

JAK3 <strong>Inhibitor</strong> VI 420126 A cell-permeable, potent inhibitor of JAK3 (IC 50 = 27 nM). Binds to the enzyme active<br />

site and prevents IL-2-induced cellular phosphorylation of JAK3 and STAT5.<br />

JAK3 <strong>Inhibitor</strong>, Negative<br />

Control<br />

420112 (4-Phenylamino-6,7-dimethoxyquinazoline; WHI-P258)<br />

A useful negative control compound for JAK3 inhibitors.<br />

Lavendustin A 428150 {5-Amino-[(N-2,5-dihydroxybenzyl)-N´-2-hydroxybenzyl]salicylic Acid; RG14355}<br />

A potent inhibitor of EGFR kinase (IC 50 = nM) and p60 c-src (IC 50 = 500 nM).<br />

Lavendustin B 428160 [5-Amino-(N,N´-bis-2-hydroxybenzyl)salicylic Acid]<br />

A negative control for Lavendustin A (IC 50 = .3 mM for EGFR kinase).<br />

Lavendustin C 234450 [Compound 5; 5-(N-2´,5´-Dihydroxybenzyl)aminosalicylic Acid]<br />

Potent inhibitor of p60c-src (IC = 200 nM) and Ca 50 2+ /calmodulin-dependent kinase II<br />

(IC = 200 nM).<br />

50<br />

N Lck <strong>Inhibitor</strong> 428205 A cell-permeable pyrrolopyrimidine compound that acts as a potent, selective and ATPcompetitive<br />

inhibitor of Lck (IC at 5 mM of ATP = < nM, 2 nM, 70 nM, .57 mM, and<br />

50<br />

.98 mM for Lck Y 64-509 394 , lckcd pY394 , src, kdr, and tie-2, respectively; IC at mM of<br />

50<br />

ATP = 6 nM, 66 nM, 26 nM, 420 nM, and 5. 8 mM for Lck Y 64-509 394 , blk, fyn, lyn, and<br />

csk, respectively). Only minimally affects the activities of other kinases (IC = 3.2 mM,<br />

50<br />

> 33 mM, > 50 mM, and > 50 mM for EGFR, PKC, CDC2/B, and ZAP-70, respectively).<br />

N<br />

Protein Tyrosine Kinase (PTK) <strong>Inhibitor</strong>s, continued<br />

LFM-A 435301 [a-Cyano-b-hydroxy-b-methyl-N-(3-fluorophenyl)propenamide]<br />

A useful negative control (IC 50 ≥ 454 mM) for LFM-A 3.<br />

LFM-A 2 435302 {a-Cyano-b-hydroxy-b-methyl-N-[4-(trifluoromethoxy)phenyl]propenamide}<br />

A potent and specific inhibitor of EGFR kinase (IC 50 = .7 mM).<br />

LFM-A 3 435300 [a-Cyano-b-hydroxy-b-methyl-N-(2,5-dibromophenyl)propenamide]<br />

A potent and specific inhibitor of Bruton’s tyrosine kinase (BTK; IC 50 = 7.2 mM for human<br />

BTK in vitro and IC 50 = 2.5 mM for recombinant BTK).<br />

Met Kinase <strong>Inhibitor</strong> 448101 (3Z)-N-(3-Chlorophenyl)-3-((3,5-dimethyl-4-((4-methylpiperazin-1-yl)carbonyl)-1Hpyrrol-2-yl)methylene)-N-methyl-2-oxo-2,3-dihydro-1H-indole-5-sulfonamide;<br />

SU11274<br />

A cell-permeable pyrrole indolinone compound that acts as a potent, reversible, and<br />

ATP-competitive inhibitor of Met kinase activity (IC = 20 nM).<br />

50<br />

500 mg $83<br />

500 mg $83<br />

25 mg $88<br />

5 mg $ 8<br />

5 mg $ 50<br />

mg $ 27<br />

0 mg $ 90<br />

0 mg $ 68<br />

5 mg $ 5<br />

50 Orders Phone 800 854 34 7<br />

Calbiochem • <strong>Inhibitor</strong> SourceBook<br />

Fax 800 776 0999<br />

Web www.emdbiosciences.com/calbiochem<br />

500 mg<br />

mg<br />

500 mg<br />

mg<br />

500 mg<br />

mg<br />

$76<br />

$ 27<br />

mg $ 7<br />

mg $ 7<br />

mg $62<br />

mg $82<br />

$44<br />

$75<br />

$ 42<br />

$230<br />

5 mg $98<br />

mg $85

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!